EOLS — Evolus, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-02-08.
Performance
Technicals
Others in Healthcare
Measured signals that fired on EOLS
| date | signal | measured base rate |
|---|---|---|
| 2026-08-11 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-05-18 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-03-20 | MOATAZEDI DAVID See Remarks | Open-market sale 10b5-1 plan | 13.7K | 4.75 | 64.9K |
| 2026-03-20 | Avelar Rui See Remarks | Open-market sale | 3.1K | 4.75 | 14.8K |
| 2026-03-17 | MOATAZEDI DAVID See Remarks | Open-market sale 10b5-1 plan | 116.7K | 4.89 | 570.8K |
| 2026-03-17 | Avelar Rui See Remarks | Open-market sale 10b5-1 plan | 30.0K | 4.89 | 146.7K |
| 2026-03-16 | MOATAZEDI DAVID See Remarks | Option exercise 10b5-1 plan | 67.5K | 0.00 | 0 |
| 2026-03-16 | Avelar Rui See Remarks | Option exercise 10b5-1 plan | 8.8K | 0.00 | 0 |
| 2026-02-17 | MOATAZEDI DAVID See Remarks | Grant or award | 313.2K | 0.00 | 0 |
| 2026-02-17 | GILL DAVID N Director | Grant or award | 45.6K | 0.00 | 0 |
| 2026-02-17 | Parschauer Karah Herdman Director | Grant or award | 45.6K | 0.00 | 0 |
| 2026-02-17 | Malik Vikram Director | Grant or award | 45.6K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Nantahala Capital Management, LLC | 26.2M | 6.4M |
| BlackRock, Inc. | 17.6M | 4.3M |
| BRAIDWELL LP | 12.8M | 3.1M |
| Frazier Life Sciences Management, L.P. | 10.8M | 2.6M |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.2M | 2.5M |
| Soleus Capital Management, L.P. | 9.2M | 2.2M |
| Stonepine Capital Management, LLC | 7.2M | 1.8M |
| MILLENNIUM MANAGEMENT LLC | 6.0M | 1.5M |
| ARMISTICE CAPITAL, LLC | 5.7M | 1.4M |
| GEODE CAPITAL MANAGEMENT, LLC | 5.7M | 1.4M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about EOLS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →